Megan Carey is a Group Leader in the Neuroscience Program at the Champalimaud Center for the Unknown in Lisbon, Portugal. She received her PhD from the University of California, San Francisco, where her thesis was awarded UCSF’s Krevans Distinguished Dissertation Award. After a Helen Hay Whitney Postdoctoral Fellowship at Harvard Medical School, Dr. Carey started her independent laboratory at the Champalimaud in 2011. Her lab combines quantitative behavioral analysis, genetics, and physiology to understand how the brain controls learned and coordinated movements.
Dr. Carey was an International Early Career Scientist of the Howard Hughes Medical Institute from 2012-2017 and received a Starting Grant from the European Research Council in 2015. She has co-chaired a number of international scientific conferences, including the Champalimaud Neuroscience Symposium, COSYNE (Computational and Systems Neuroscience, Utah, USA), the Gordon Research Conference on the Cerebellum (Maine, USA), and the Forum of the Federation of European Neuroscience Societies (FENS, Copenhagen, Denmark, 2016; Berlin, Germany, 2018). She is a Scholar, and the current Chair, of the FENS Kavli Network of Excellence. Dr. Carey has served on the Open Science panel of the RISE high-level advisory group to the European Commission since 2015.